Julia Dubois
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Twenty-five years of human metapneumovirus research.
Journal: Clinical microbiology reviews
Published: July 10, 2026
Landscape of Prophylactic Strategies Against Human Parainfluenza Virus Type 3.
Journal: Reviews in medical virology
Published: May 30, 2025
Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor.
Journal: NPJ vaccines
Published: March 13, 2025
Author Correction: Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.
Journal: NPJ vaccines
Published: July 09, 2024
Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®.
Journal: Vaccines
Published: September 13, 2021
Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.
Journal: Microorganisms
Published: November 03, 2020
Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.
Journal: The Journal of infectious diseases
Published: May 23, 2020
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Journal: Cell reports. Medicine
Published: April 22, 2020
Last Updated: 09/26/2026